The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Molecular and cellular regulation of human glucokinase
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Biophysical investigations of naturally occurring GCK mutants have led to the identification of two distinct mechanisms of enzyme activation, termed a-type and b-type (31,60).”
From Nanosecond-Timescale Dynamics and Conformational Heterogeneity in Human GCK Regulation and Disease (2020) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Komander, D., & Rape, M. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060310-170328 · Cited by 3,679
Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function
Wilson, J. E. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00241 · Cited by 1,085 · cited 3×
“The ADP produced by GCK can then activate mitochondrial respiration.[11,50,78] Seemingly, these unique metabolic and survival functions of BAD could be selectively targeted by therapeutics.”
BackgroundBAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis
Danial, N. N., Gramm, C. F., Scorrano, L., Zhang, C.-Y., Krauss, S., Ranger, A. M., Robert Datta, S., Greenberg, M. E., Licklider, L. J., Lowell, B. B., et al. (2003) · Nature · doi:10.1038/nature01825 · Cited by 705
Diabetes mellitus and genetically programmed defects in β-cell function
Bell, G. I., & Polonsky, K. S. (2001) · Nature · doi:10.1038/414788a · Cited by 475
Molecular Physiology of Mammalian Glucokinase
Iynedjian, P. B. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8322-9 · Cited by 365
Dual role of proapoptotic BAD in insulin secretion and beta cell survival
Danial, N. N., Walensky, L. D., Zhang, C.-Y., Choi, C. S., Fisher, J. K., Molina, A. J. A., Datta, S. R., Pitter, K. L., Bird, G. H., Wikstrom, J. D., et al. (2008) · Nature Medicine · doi:10.1038/nm1717 · Cited by 307
Boudina, S., Bugger, H., Sena, S., O'Neill, B. T., Zaha, V. G., Ilkun, O., Wright, J. J., Mazumder, P. K., Palfreyman, E., Tidwell, T. J., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.792101 · Cited by 301
Glucokinase regulatory protein: complexity at the crossroads of triglyceride and glucose metabolism
Raimondo, A., Rees, M. G., & Gloyn, A. L. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000155 · Cited by 118 · cited 1×
“[44,45] For a more in depth treatment of the subject, the reader is referred to several excellent recent reviews.[27,46,47]”
BackgroundInsulin Signaling Regulates Mitochondrial Function in Pancreatic β-Cells
Liu, S., Okada, T., Assmann, A., Soto, J., Liew, C. W., Bugger, H., Shirihai, O. S., Abel, E. D., & Kulkarni, R. N. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007983 · Cited by 58
Research works printed but not linked: 141
- Wilson, 1995, Hexokinases, Rev. Physiol. Biochem. Pharmacol., 126, 65, 10.1007/BFb0049776 · DOI · Paper page
- Ferre, 1996, Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver, FASEB J., 10, 1213, 10.1096/fasebj.10.10.8751724 · DOI · Paper page
- Printz, 1993, Mammalian glucokinase, Annu. Rev. Nutr., 10.1146/annurev.nu.13.070193.002335 · DOI · Paper page
- Iynedjian, 1993, Mammalian glucokinase and its gene, Biochem. J., 293, 1, 10.1042/bj2930001 · DOI · Paper page
- Matschinsky, 1990, Glucokinase as glucose sensor and metabolic signal generator in pancreatic β-cells and hepatocytes, Diabetes, 39, 647, 10.2337/diab.39.6.647 · DOI · Paper page
- Kawai, 2005, Structures, evolution, and ancestor of glucose kinases in the hexokinase family, J. Biosci. Bioeng., 10.1263/jbb.99.320 · DOI
- Cárdenas, 1998, Evolution and regulatory role of the hexokinases, Biochim. Biophys. Acta Mol. Cell Res., 1401, 242, 10.1016/S0167-4889(97)00150-X · DOI · Paper page
- Aiston, 1999, Glucose-6-phosphatase overexpression lowers glucose 6-phosphate and inhibits glycogen synthesis and glycolysis in hepatocytes without affecting glucokinase translocation. Evidence against feedback inhibition of glucokinase, J. Biol. Chem., 10.1074/jbc.274.35.24559 · DOI
- Osbak, 2009, Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia, Hum. Mutat., 30, 1512, 10.1002/humu.21110 · DOI · Paper page
- Kim, 2015, Maturity-onset diabetes of the young: what do clinicians need to know?, Diabetes Metab. J., 39, 468, 10.4093/dmj.2015.39.6.468 · DOI
- Matschinsky, 2011, Glucokinase activators for diabetes therapy: may 2010 status report, Diabetes Care, 10.2337/dc11-s236 · DOI
- Bowler, 2013, Small-molecule allosteric activation of human glucokinase in the absence of glucose, ACS Med. Chem. Lett., 10.1021/ml400061x · doi:10.1021/ml400061x
- Grewal, 2014, Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus, Mini Rev. Med. Chem., 10.2174/1389557514666140722082713 · doi:10.2174/1389557514666140722082713
- Xiao, 2013, Enantioselective synthesis of tatanans A-C and reinvestigation of their glucokinase-activating properties, Nat. Chem., 10.1038/nchem.1597 · doi:10.1038/nchem.1597
- Shelton, 1992, Multiple elements in the upstream glucokinase promoter contribute to transcription in insulinoma cells, Mol. Cell Biol.
- Jetton, 1994, Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut, J. Biol. Chem., 269, 3641, 10.1016/S0021-9258(17)41910-7 · DOI · Paper page
- Moates, 2004, The Pal elements in the upstream glucokinase promoter exhibit dyad symmetry and display cell-specific enhancer activity when multimerised, Diabetologia, 10.1007/s00125-004-1497-1 · DOI
- Moates, 2003, BETA2 activates transcription from the upstream glucokinase gene promoter in islet β-cells and gut endocrine cells, Diabetes, 10.2337/diabetes.52.2.403 · DOI
- Iynedjian, 1988, Stimulation by insulin of glucokinase gene transcription in liver of diabetic rats, J. Biol. Chem., 263, 740, 10.1016/S0021-9258(19)35415-8 · DOI · Paper page
- Wu, 2004, A potential role for fructose-2,6-bisphosphate in the stimulation of hepatic glucokinase gene expression, Endocrinology, 10.1210/en.2003-1290 · DOI
- Roth, 2004, The transcription factors HIF-1 and HNF-4 and the coactivator p300 are involved in insulin-regulated glucokinase gene expression via the phosphatidylinositol 3-kinase/protein kinase B pathway, J. Biol. Chem., 10.1074/jbc.M308391200 · DOI
- Iynedjian, 1995, Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes, J. Clin. Invest., 95, 10.1172/JCI117880 · DOI
- Agius, 2016, Hormonal and metabolite regulation of hepatic glucokinase, Annu. Rev. Nutr., 36, 389, 10.1146/annurev-nutr-071715-051145 · DOI
- Kamata, 2004, Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase, Structure, 12, 429, 10.1016/j.str.2004.02.005 · DOI · Paper page
- Nishimura, 2009, Identification of novel and potent 2-amino benzamide derivatives as allosteric glucokinase activators, Bioorg. Med. Chem. Lett, 19, 1357, 10.1016/j.bmcl.2009.01.053 · DOI · Paper page
- Pal, 2009, Activating mutations in the human glucokinase gene revealed by genetic selection, Biochemistry, 48, 814, 10.1021/bi802142q · doi:10.1021/bi802142q
- Liu, 2012, Insights into mechanism of glucokinase activation: observation of multiple distinct protein conformations, J. Biol. Chem.
- Richard, 1974, Regulatory behavior of monomeric enzymes: 1. The mnemonical enzyme concept, Eur. J. Biochem., 10.1111/j.1432-1033.1974.tb03825.x · doi:10.1111/j.1432-1033.1974.tb03825.x
- Ainslie, 1972, Transients and cooperativity. A slow transition model for relating transients and cooperative kinetics of enzymes, J. Biol. Chem., 247, 7088, 10.1016/S0021-9258(19)44697-8 · DOI · Paper page
- Neet, 1990, Observation of a kinetic slow transition in monomeric glucokinase, Biochemistry, 10.1021/bi00455a026 · doi:10.1021/bi00455a026
- Heredia, 2006, Biochemical basis of glucokinase activation and the regulation by glucokinase regulatory protein in naturally occurring mutations, J. Biol. Chem., 281, 40201, 10.1074/jbc.M607987200 · DOI
- Antoine, 2009, Binding kinetics of glucose and allosteric activators to human glucokinase reveal multiple conformational states, Biochemistry, 10.1021/bi900374c · DOI
- Whittington, 2015, Dual allosteric activation mechanisms in monomeric human glucokinase, Proc. Natl. Acad. Sci. U.S.A., 112, 11553, 10.1073/pnas.1506664112 · DOI · Paper page
- Larion, 2012, Order-disorder transitions govern kinetic cooperativity and allostery of monomeric human glucokinase, PLoS Biol., 10, 10.1371/journal.pbio.1001452 · DOI · Paper page
- Sternisha, 2018, Mechanistic origins of enzyme activation in human glucokinase variants associated with congenital hyperinsulinism, Biochemistry, 10.1021/acs.biochem.8b00022 · DOI · Paper page
- Bowler, 2013, Small-molecule allosteric activation of human glucokinase in the absence of glucose, ACS Med. Chem. Lett., 4, 580, 10.1021/ml400061x · doi:10.1021/ml400061x
- Van Schaftingen, 1989, A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6‐phosphate and fructose 1‐phosphate, Eur. J. Biochem., 179, 179, 10.1111/j.1432-1033.1989.tb14538.x · DOI · Paper page
- Van Schaftingen, 1992, The regulatory protein of liver glucokinase, Adv. Enzym. Regul., 32, 133, 10.1016/0065-2571(92)90013-P · DOI
- Choi, 2013, Molecular basis for the role of glucokinase regulatory protein as the allosteric switch for glucokinase, Proc. Natl. Acad. Sci. U.S.A., 110, 10171, 10.1073/pnas.1300457110 · DOI
- Beck, 2013, Structural basis for regulation of human glucokinase by glucokinase regulatory protein, Biochemistry, 52, 6232, 10.1021/bi400838t · DOI
- Lenzen, 2014, A fresh view of glycolysis and glucokinase regulation: history and current status, J. Biol. Chem., 289, 12189, 10.1074/jbc.R114.557314 · DOI · Paper page
- Shiota, 1999, Nuclear import of hepatic glucokinase depends upon glucokinase regulatory protein, whereas export is due to a nuclear export signal sequence in glucokinase, J. Biol. Chem., 274, 37125, 10.1074/jbc.274.52.37125 · DOI
- Agius, 2008, Glucokinase and molecular aspects of liver glycogen metabolism, Biochem. J., 414, 1, 10.1042/BJ20080595 · DOI · Paper page
- Arden, 2006, Glucokinase regulatory protein is associated with mitochondria in hepatocytes, FEBS Lett., 580, 2065, 10.1016/j.febslet.2006.03.009 · DOI
- Johansson, 2017, Nuclear import of glucokinase in pancreatic beta-cells is mediated by a nuclear localization signal and modulated by SUMOylation, Mol. Cell. Endocrinol., 454, 146, 10.1016/j.mce.2017.06.020 · DOI
- Anderka, 2008, Biophysical characterization of the interaction between hepatic glucokinase and its regulatory protein: impact of physiological and pharmacological effectors, J. Biol. Chem., 283, 31333, 10.1074/jbc.M805434200 · DOI
- Pautsch, 2013, Supporting Information Crystal structure of glucokinase regulatory protein, Biochemistry, 52, 1, 10.1021/bi4000782 · DOI
- Lloyd, 2013, Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors, Nature, 504, 437, 10.1038/nature12724 · DOI
- Casey, 2016, Kinetic basis of carbohydrate-mediated inhibition of human glucokinase by the glucokinase regulatory protein, Biochemistry, 10.1021/acs.biochem.6b00349 · doi:10.1021/acs.biochem.6b00349
- Martinez, 2017, Antidiabetic disruptors of the glucokinase-glucokinase regulatory protein complex reorganize a coulombic interface, Biochemistry, 10.1021/acs.biochem.7b00377 · DOI
- Park, 2015, Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity, Sci. Rep., 5, 1, 10.1038/srep17395 · DOI
- Watanabe, 2018, Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein, Nat. Commun., 9, 1, 10.1038/s41467-017-02537-6 · DOI
- Veiga-Da-Cunha, 2009, Evolution of vertebrate glucokinase regulatory protein from a bacterial N-acetylmuramate 6-phosphate etherase, Biochem. J., 423, 323, 10.1042/BJ20090986 · DOI
- Orho-Melander, 2008, Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations, Stroke, 57, 3112
- Sparsø, 2008, The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes, Diabetologia, 51, 70, 10.1007/s00125-007-0865-z · DOI · Paper page
- Baltrusch, 2001, Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library: identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel interaction partner, J. Biol. Chem., 276, 43915, 10.1074/jbc.M105470200 · DOI
- Smith, 2007, Molecular coordination of hepatic glucose metabolism by the 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase:glucokinase complex, Mol. Endocrinol., 21, 1478, 10.1210/me.2006-0356 · doi:10.1210/me.2006-0356
- Baltrusch, 2012, Additive activation of glucokinase by the bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and the chemical activator LY2121260, Biochem. Pharmacol., 83, 1300, 10.1016/j.bcp.2012.01.020 · doi:10.1016/j.bcp.2012.01.020
- Massa, 2004, Interaction of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2) with glucokinase activates glucose phosphorylation and glucose metabolism in insulin-producing cells, Diabetes, 53, 1020, 10.2337/diabetes.53.4.1020 · DOI
- Cullen, 2011, Susceptibility of glucokinase-MODY mutants to inactivation by oxidative stress in pancreatic β-cells, Diabetes, 10.2337/db11-0423 · DOI
- Tiedge, 2000, Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase, Arch. Biochem. Biophys., 375, 251, 10.1006/abbi.1999.1666 · DOI
- Baltrusch, 2007, Novel insights into the regulation of the bound and diffusible glucokinase in MIN6 β-cells, Diabetes, 56, 1305, 10.2337/db06-0894 · DOI
- Payne, 2007, Contributions of glucokinase and phosphofructokinase-2/fructose bisphosphatase-2 to the elevated glycolysis in hepatocytes from Zucker fa/fa rats, Am. J. Physiol. Regul. Integr. Comp. Physiol., 293, R618, 10.1152/ajpregu.00061.2007 · DOI
- Cullen, 2014, Glucagon induces translocation of glucokinase from the cytoplasm to the nucleus of hepatocytes by transfer between 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase-2 and the glucokinase regulatory protein, Biochim. Biophys. Acta Mol. Cell Res., 1843, 1123, 10.1016/j.bbamcr.2014.02.006 · DOI
- Langer, 2010, Endogenous activation of glucokinase by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase is glucose dependent, Mol. Endocrinol., 24, 10.1210/me.2010-0115 · doi:10.1210/me.2010-0115
- Mukhtar, 2008, Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, AJP Regul. Integr. Comp. Physiol., 10.1152/ajpregu.00593.2007 · DOI
- Payne, 2005, Dual role of phosphofructokinase-2/fructose bisphosphatase-2 in regulating the compartmentation and expression of glucokinase in hepatocytes, Diabetes, 54, 1949, 10.2337/diabetes.54.7.1949 · DOI
- Watanabe, 2010, Quantitative image analysis reveals that phosphorylation of liver-type isozyme of fructose-6-phosphate 2-kinase/fructose-2,6-bisphosphatase does not affect nuclear translocation of glucokinase in rat primary hepatocytes, J. Biochem., 148, 713, 10.1093/jb/mvq107 · DOI
- Yang, 2010, Molecular modeling of BAD complex resided in a mitochondrion integrating glycolysis and apoptosis, J. Theor. Biol., 266, 231, 10.1016/j.jtbi.2010.06.009 · DOI
- Danial, 2009, Bad: undertaker by night, candyman by day, Oncogene, 27
- Szlyk, 2014, A phospho-BAD BH3 helix activates glucokinase by a mechanism distinct from that of allosteric activators, Nat. Struct. Mol. Biol., 21, 36, 10.1038/nsmb.2717 · DOI
- Lee, 2009, Mitochondrial dysfunction: glucokinase downregulation lowers interaction of glucokinase with mitochondria, resulting in apoptosis of pancreatic β-cells, Cell. Signal., 21, 69, 10.1016/j.cellsig.2008.09.015 · DOI
- Giménez-Cassina, 2014, Regulation of hepatic energy metabolism and gluconeogenesis by BAD, Cell Metabol., 19, 272, 10.1016/j.cmet.2013.12.001 · DOI
- Rexford, 2017, Biochemical and biophysical investigations of the interaction between human glucokinase and pro-apoptotic BAD, PLoS One, 12, 10.1371/journal.pone.0171587 · DOI
- Zhang, 2002, Development of a high-throughput fluorescence polarization assay for Bcl-xL, Anal. Biochem., 307, 70, 10.1016/S0003-2697(02)00028-3 · DOI
- Yu, 2004, JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD, Mol. Cell., 13, 329, 10.1016/S1097-2765(04)00028-0 · DOI · Paper page
- Grimsby, 2000, Characterization of glucokinase regulatory protein-deficient mice, J. Biol. Chem., 275, 7826, 10.1074/jbc.275.11.7826 · DOI
- Bjørkhaug, 2007, Allosteric activation of human glucokinase by free polyubiquitin chains and its ubiquitin-dependent cotranslational proteasomal degradation, J. Biol. Chem., 282, 22757, 10.1074/jbc.M700517200 · DOI
- Yan, 2005, Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels, Am. J. Physiol. Cell Physiol., 289, C1351, 10.1152/ajpcell.00240.2005 · DOI
- Kitiphongspattana, 2005, Proteasome inhibition alters glucose-stimulated (pro)insulin secretion and turnover in pancreatic β-cells, J. Biol. Chem., 280, 15727, 10.1074/jbc.M410876200 · DOI
- Kawaguchi, 2006, Essential role of ubiquitin-proteasome system in normal regulation of insulin secretion, J. Biol. Chem., 281, 13015, 10.1074/jbc.M601228200 · DOI
- López-Avalos, 2006, Evidence for a role of the ubiquitin-proteasome pathway in pancreatic islets, Diabetes, 55, 1223, 10.2337/db05-0450 · DOI
- Callis, 2014, The ubiquitination machinery of the ubiquitin system, Arab. B., 12, e0174, 10.1199/tab.0174 · DOI · Paper page
- Hofmeister-Brix, 2013, Identification of the ubiquitin-like domain of midnolin as a new glucokinase interaction partner, J. Biol. Chem., 288, 35824, 10.1074/jbc.M113.526632 · DOI
- Grabbe, 2009, Functional roles of ubiquitin-like domain (ULD) and ubiquitin-binding domain (UBD) containing proteins, Chem. Rev., 10.1021/cr800413p · DOI
- Walters, 2004, Ubiquitin family proteins and their relationship to the proteasome: a structural perspective, Biochim. Biophys. Acta Mol. Cell Res., 10.1016/j.bbamcr.2004.10.005 · DOI
- Nandi, 2006, The ubiquitin-proteasome system, J. Biosci., 31, 137, 10.1007/BF02705243 · DOI · Paper page
- Ravid, 2008, Diversity of degradation signals in the ubiquitin-proteasome system, Nat. Rev. Mol. Cell Biol., 9, 679, 10.1038/nrm2468 · DOI · Paper page
- Kravtsova-Ivantsiv, 2012, Non-canonical ubiquitin-based signals for proteasomal degradation, J. Cell Sci., 125, 539, 10.1242/jcs.093567 · DOI · Paper page
- Muratani, 2003, How the ubiquitin-proteasome system controls transcription, Nat. Rev. Mol. Cell Biol., 4, 192, 10.1038/nrm1049 · DOI · Paper page
- Hofmeister-Brix, 2013, The ubiquitin-proteasome system regulates the stability and activity of the glucose sensor glucokinase in pancreatic β-cells, Biochem. J., 456, 173, 10.1042/BJ20130262 · DOI
- Flotho, 2013, Sumoylation: a regulatory protein modification in health and disease, Annu. Rev. Biochem., 82, 357, 10.1146/annurev-biochem-061909-093311 · DOI · Paper page
- Bologna, 2013, It takes two to tango: ubiquitin and SUMO in the DNA damage response, Front. Genet., 4, 10.3389/fgene.2013.00106 · DOI
- Jackson, 2013, Regulation of DNA damage responses by ubiquitin and SUMO, Mol. Cell., 49, 795, 10.1016/j.molcel.2013.01.017 · DOI · Paper page
- Johnson, 2004, Protein modification by SUMO, Annu. Rev. Biochem., 73, 355, 10.1146/annurev.biochem.73.011303.074118 · DOI · Paper page
- Gareau, 2010, The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition, Nat. Rev. Mol. Cell Biol., 11, 861, 10.1038/nrm3011 · DOI · Paper page
- Geiss-friedlander, 2007, Concepts in sumoylation: a decade on, Nat. Rev. Mol. Cell Biol., 8, 947, 10.1038/nrm2293 · DOI · Paper page
- Miura, 2007, Sumoylation, a post-translational regulatory process in plants, Curr. Opin. Plant Biol., 10, 495, 10.1016/j.pbi.2007.07.002 · DOI · Paper page
- Wilkinson, 2012, Mechanisms, regulation and consequences of protein SUMOylation, Biochem. J., 428, 133, 10.1042/BJ20100158 · DOI · Paper page
- Kanakousaki, 2012, A differential requirement for SUMOylation in proliferating and non-proliferating cells during Drosophila development, Development, 139, 2751, 10.1242/dev.082974 · doi:10.1242/dev.082974
- Bawa-Khalfe, 2010, SUMO losing balance: SUMO proteases disrupt SUMO homeostasis to facilitate cancer development and progression, Genes Canc., 1, 748, 10.1177/1947601910382555 · DOI
- Wang, 2004, SUMO-1 modification activated GATA4-dependent cardiogenic gene activity, J. Biol. Chem., 279, 49091, 10.1074/jbc.M407494200 · DOI
- Aukrust, 2013, SUMOylation of pancreatic glucokinase regulates its cellular stability and activity, J. Biol. Chem., 288, 5951, 10.1074/jbc.M112.393769 · DOI
- Galán, 2006, Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability, Biochem. J., 393, 389, 10.1042/BJ20051137 · DOI
- V Burke, 1999, Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI), Biochem. J., 342, 345, 10.1042/bj3420345 · DOI
- Grimsby, 2003, Allosteric activators of glucokinase: potential role in diabetes therapy, Science, 301, 370, 10.1126/science.1084073 · DOI · Paper page
- Caron, 2013, Annexin A1 is regulated by domains cross-talk through post-translational phosphorylation and SUMOYlation, Cell. Signal, 25, 1962, 10.1016/j.cellsig.2013.05.028 · DOI
- Jongjitwimol, 2016, Sumoylation of eIF4A2 affects stress granule formation, J. Cell Sci., 129, 2407, 10.1242/jcs.184614 · DOI
- Ulrich, 2005, SUMO modification: wrestling with protein conformation, Curr. Biol., 15, 10.1016/j.cub.2005.03.021 · doi:10.1016/j.cub.2005.03.021
- a Campbell, 2008, Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1), Mol. Cell Biol., 28, 7476, 10.1128/MCB.00103-08 · DOI
- Dai, 2011, SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans, Diabetes, 60, 838, 10.2337/db10-0440 · DOI · Paper page
- Toyoda, 1997, Glucokinase is located in secretory granules of pancreatic D-cells, FEBS Lett., 415, 281, 10.1016/S0014-5793(97)01139-3 · DOI
- Toyoda, 1999, Glucokinase is concentrated in insulin-secretory granules of pancreatic B-cells, Histochem, Cell Biol., 112, 35
- Stubbs, 2000, Subcellular localization, mobility, and kinetic activity of glucokinase in glucose-responsive insulin-secreting cells, Diabetes, 49, 2048, 10.2337/diabetes.49.12.2048 · DOI
- Markwardt, 2012, Association with nitric oxide synthase on insulin secretory granules regulates glucokinase protein levels, Mol. Endocrinol., 26, 1617, 10.1210/me.2012-1183 · DOI
- Rizzo, 2002, A functional link between glucokinase binding to insulin granules and conformational alterations in response to glucose and insulin, J. Biol. Chem., 277, 34168, 10.1074/jbc.M112478200 · DOI
- Rizzo, 2003, Regulation of β cell glucokinase by S-nitrosylation and association with nitric oxide synthase, J. Cell Biol., 161, 243, 10.1083/jcb.200301063 · DOI
- Arden, 2004, Glucokinase is an integral component of the insulin granules in glucose-responsive insulin secretory cells and does not translocate during glucose stimulation, Diabetes, 53, 2346, 10.2337/diabetes.53.9.2346 · DOI
- Ding, 2010, Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation, Mol. Endocrinol., 24, 171, 10.1210/me.2009-0138 · DOI
- Tiedge, 2000, Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase, Arch. Biochem. Biophys., 10.1006/abbi.1999.1666 · DOI
- Markwardt, 2016, Regulation of glucokinase by intracellular calcium levels in pancreatic β cells, J. Biol. Chem., 10.1074/jbc.M115.692160 · DOI
- Ding, 2011, Glucagon-like peptide 1 stimulates post-translational activation of glucokinase in pancreatic β cells, J. Biol. Chem., 10.1074/jbc.M110.192799 · DOI
- Weir, 1989, Glucagonlike peptide I (7-37) actions on endocrine pancreas, Diabetes, 10.2337/diab.38.3.338 · DOI · Paper page
- Seckinger, 2018, Nitric oxide activates β-cell glucokinase by promoting formation of the “glucose-Activated” state, Biochemistry, 57, 5136, 10.1021/acs.biochem.8b00333 · DOI
- Murata, 1997, Co-localization of glucokinase with actin filaments, FEBS Lett., 406, 109, 10.1016/S0014-5793(97)00253-6 · DOI
- Magnuson, 1992, Tissue-specific regulation of glucokinase gene expression, J. Cell. Biochem., 48, 115, 10.1002/jcb.240480202 · DOI
- Balasubramanian, 2007, A role for F-actin in hexokinase-mediated glucose signaling, Plant Physiol., 145, 1423, 10.1104/pp.107.108704 · DOI
- Balasubramanian, 2008, Actin-based cellular framework for glucose signaling by Arabidopsis hexokinase1, Plant Signal. Behav., 3, 322, 10.4161/psb.3.5.5319 · DOI
- Wagner, 1999, Viscoelastic properties of f-actin, microtubules, f-actin/α-actinin, and f-actin/Hexokinase determined in microliter volumes with a novel nondestructive method, biophys, J, 76, 2784
- Fields, 1989, A novel genetic system to detect protein-protein interactions. [Yeast two hybrid], Nature, 340, 245, 10.1038/340245a0 · DOI · Paper page
- Fields, 1994, The two-hybrid system: an assay for protein-protein interactions, Trends Genet., 10, 286, 10.1016/0168-9525(90)90012-U · DOI · Paper page
- Stynen, 2012, Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system, Microbiol. Mol. Biol. Rev., 76, 331, 10.1128/MMBR.05021-11 · DOI · Paper page
- Muñoz-Alonso, 2000, A novel cytosolic dual specificity phosphatase, interacting with glucokinase, increases glucose phosphorylation rate, J. Biol. Chem., 275, 32406, 10.1074/jbc.M000841200 · DOI
- Renatus, 2012, Phosphorylation meets proteolysis, Structure, 20, 570, 10.1016/j.str.2012.03.006 · doi:10.1016/j.str.2012.03.006
- Shiraishi, 2001, A novel glucokinase regulator in pancreatic β cells. Precursor of propionyl-CoA carboxylase β subunit interacts with glucokinase and augments its activity, J. Biol. Chem., 276, 2325, 10.1074/jbc.C000530200 · DOI
- V Bhagavan, 2013, Essentials of medical biochemistry with clinical cases, Essentials Med. Biochem., 151
- Baltrusch, 2006, Glucokinase regulatory network in pancreatic β-cells and liver, Diabetes, 10.2337/db06-S008 · DOI
- Schmitt, 2017, Spatial organization of metabolic enzyme complexes in cells, Biochemistry, 10.1021/acs.biochem.7b00249 · DOI
- Kohnhorst, 2017, Identification of a multienzyme complex for glucose metabolism in living cells, J. Biol. Chem., 10.1074/jbc.M117.783050 · DOI
- Baltrusch, 2006, Improved metabolic stimulus for glucose-induced insulin secretion through GK and PFK-2/FBPase-2 coexpression in insulin-producing RINm5F cells, Endocrinology, 147, 5768, 10.1210/en.2006-0694 · DOI
- Arden, 2008, A role for PFK-2/FBPase-2, as distinct from fructose 2,6-bisphosphate, in regulation of insulin secretion in pancreatic beta-cells, Biochem. J., 411, 41, 10.1042/BJ20070962 · DOI
Cited by
Accurate proteome-wide missense variant effect prediction with AlphaMissense
Cheng, J., Novati, G., Pan, J., Bycroft, C., Žemgulytė, A., Applebaum, T., Pritzel, A., Wong, L. H., Zielinski, M., Sargeant, T., et al. (2023) · Science · doi:10.1126/science.adg7492 · Cited by 2,163
A comprehensive map of human glucokinase variant activity
Gersing, S., Cagiada, M., Gebbia, M., Gjesing, A. P., Coté, A. G., Seesankar, G., Li, R., Tabet, D., Weile, J., Stein, A., et al. (2023) · Genome Biology · doi:10.1186/s13059-023-02935-8 · Cited by 55
Dos Santos, R. S., Medina-Gali, R. M., Babiloni-Chust, I., Marroqui, L., & Nadal, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095040 · Cited by 28
Characterizing glucokinase variant mechanisms using a multiplexed abundance assay
Gersing, S., Schulze, T. K., Cagiada, M., Stein, A., Roth, F. P., Lindorff-Larsen, K., & Hartmann-Petersen, R. (2024) · Genome Biology · doi:10.1186/s13059-024-03238-2 · Cited by 23
Nanosecond-Timescale Dynamics and Conformational Heterogeneity in Human GCK Regulation and Disease
Sternisha, S. M., Whittington, A. C., Martinez Fiesco, J. A., Porter, C., McCray, M. M., Logan, T., Olivieri, C., Veglia, G., Steinbach, P. J., & Miller, B. G. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2019.12.036 · Cited by 17
Self-citation
Metadata
- Authors
- Sternisha, S. M., & Miller, B. G.
- Venue
- Archives of Biochemistry and Biophysics
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 663
- Pages
- 199-213
- ISSN
- 0003-9861
- Cited by
- 143
- References
- 9
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- NIH (GM115388)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular and cellular regulation of human glucokinase. https://app.cochat.ai/papers/10.1016/j.abb.2019.01.011
- The paper
- Sternisha, S. M., & Miller, B. G. (2019). Molecular and cellular regulation of human glucokinase. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2019.01.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.